Researchers confirm pine bark extract could reduce cataract risk

April 25, 2013

(Medical Xpress)—A winter after discovering Canada for France, Jacques Cartier's exploration crew started suffering and dying from the dreadful scurvy disease in 1535. But thanks to an Iroquoian healer, they were miraculously cured by a tea made from pine bark.

Nearly 500 years later, a research team from Western has found that an over-the-counter pill boasting the same antioxidants may reduce risk of cataracts – the clouding of the normally clear lens of an eye – when delivered through the correct method.

The findings were recently published in Current Eye Research, Informa Healthcare.

John R. Trevithick and his colleagues from Western's Faculty of Health Sciences and the Schulich School of Medicine & Dentistry, along with Dr. Ernest Sanford, have found that treating cataracts with dietary pycnogenol shows positive results on eye lenses and no negative short-term impact.

There is still a possibility that over the long-term, pycnogenol could lead to the formation of elevated peroxide concentrations – in environments with high concentrations of oxygen or light – which could potentially activate the and damage the lens.

Trevithick says further testing on the extract is also needed as testing in vitro (when organisms have been isolated from their usual biological surroundings) actually accelerated cataract production, causing further tissue damage. A potential counter measure to this adverse effect could be having patients supplement with beta carotene, Vitamin C and E boosters.

According to Trevithick, combinations of pycnogenol with beta carotene and Vitamin C have already shown promising results for reducing caused by space radiation in Mars mission simulations.

"Pycnogenol has been marketed as an antioxidant for a long time but this is definitely an exciting opportunity for its healing effects if we can make this work," said Trevithick, a biochemistry and kinesiology professor emeritus.

With Canada's wealth of Jack pine trees growing from the Northwest Territories to Nova Scotia, Trevithick offers that the development of a Canadian variety of pycnogenol would make an excellent spinoff product for the country's pulp and paper industry.

Explore further: No support shown for the use of pycnogenol for chronic disorders

Related Stories

No support shown for the use of pycnogenol for chronic disorders

February 15, 2012
The manufacturer of a dietary supplement made from French pine bark, Pycnogenol, markets it widely for the prevention or treatment of many chronic disorders, ranging from asthma to erectile dysfunction, but a recent systematic ...

Recommended for you

Researchers report startling glaucoma protein discovery

October 20, 2017
A discovery in a protein associated with glaucoma was so unheard of that for over two years, researchers ran it through a gauntlet of lab tests and published a new research paper on it. The tests validated what they initially ...

Curve-eye-ture: How to grow artificial corneas

October 19, 2017
Scientists at Newcastle University, UK, and the University of California have developed a new method to grow curved human corneas improving the quality and transparency - solely by controlling the behaviour of cells in a ...

Clinical study success for novel contact lens device aimed to improve glaucoma treatment

October 19, 2017
A novel contact lens device developed by University of Liverpool engineers to improve the treatment of glaucoma has been found to reliably track pressure changes in the eye and be wearable by people who took part in its first ...

Study indicates proof of concept for using a surrogate liquid biopsy to provide genetic profile of retinoblastoma tumors

October 12, 2017
Retinoblastoma is a tumor of the retina that generally affects children under 5 years of age. If not diagnosed early, retinoblastoma may result in loss of one or both eyes and can be fatal. Unlike most cancers that are diagnosed ...

Farsighted children struggle with attention, study finds

October 10, 2017
Farsighted preschoolers and kindergartners have a harder time paying attention and that could put them at risk of slipping behind in school, a new study suggests.

New drug reduces rate of progression of incurable eye disease

October 4, 2017
An international study including researchers from the Centre for Eye Research Australia (CERA) has found a way to slow the progression of dry age-related macular degeneration (AMD) - one of the most common causes of vision ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.